Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

SWHFX Schwab Health Care

  • Fund
  • SWHFX
  • Price as of: May 22, 2019
  • $23.74 + $0.14 + 0.59%
  • Category
  • Health & Biotech Equities

SWHFX - Profile

Vitals

  • YTD Return 3.5%
  • 3 Yr Annualized Return 2.3%
  • 5 Yr Annualized Return -0.9%
  • Net Assets $801 M
  • Holdings in Top 10 42.3%

52 WEEK LOW AND HIGH

$23.74
$21.59
$27.84

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.80%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 45.00%

TRADING FEES

  • Max Redemption Fee 2.00%

Min Investment

STANDARD (TAXABLE)

$0

IRA

N/A

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 3.5%
  • 3 Yr Annualized Total Return 2.3%
  • 5 Yr Annualized Total Return -0.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.91%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Schwab Health Care Fund™
  • Fund Family Name Schwab Funds
  • Inception Date Jul 03, 2000
  • Shares Outstanding 33622683
  • Share Class No Load
  • Currency USD
  • Domiciled Country United States
  • Manager Jonas Svallin

Fund Description

The Schwab Health Care Fund (SWHFX) is a low-cost, actively managed fund focusing on the health care sector. This includes drug and biotechnology companies, health care facilities operators, medical device manufacturers, medical providers and health insurance firms. The fund’s managers use fundamental analyses to find stocks that have the potential for growth. SWHFX is free to own stocks of any market capitalization as well as international stocks.

Given its single-sector focus, SWHFX is best suited as a satellite position in a broad equity portfolio. The fund is managed by Charles Schwab Investment Management Inc.

SWHFX - Performance

Return Ranking - Trailing

Period SWHFX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.5% -4.3% 27.1% 86.27%
1 Yr -3.9% -23.4% 7.2% 43.14%
3 Yr 2.3%* -16.9% 24.9% 60.78%
5 Yr -0.9%* -11.4% 18.4% 66.33%
10 Yr 7.4%* -1.8% 16.1% 65.43%

* Annualized


Return Ranking - Calendar

Period SWHFX Return Category Return Low Category Return High Rank in Category (%)
2018 -5.3% -25.3% 7.7% 32.35%
2017 11.9% -10.8% 43.9% 70.59%
2016 -6.8% -29.8% 2.6% 15.69%
2015 -7.0% -20.4% 13.8% 77.45%
2014 7.2% -5.8% 31.5% 82.65%

Total Return Ranking - Trailing

Period SWHFX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.5% -4.3% 27.1% 86.27%
1 Yr -3.9% -23.4% 11.3% 49.02%
3 Yr 2.3%* -16.9% 28.1% 78.43%
5 Yr -0.9%* -11.4% 20.4% 84.69%
10 Yr 7.4%* -1.8% 18.6% 82.72%

* Annualized


Total Return Ranking - Calendar

Period SWHFX Return Category Return Low Category Return High Rank in Category (%)
2018 -5.3% -25.3% 12.3% 41.18%
2017 11.9% -10.8% 45.8% 81.37%
2016 -6.8% -24.2% 8.7% 20.59%
2015 -7.0% -16.6% 15.2% 81.37%
2014 7.2% -5.8% 36.7% 89.80%

NAV & Total Return History

SWHFX - Holdings

Concentration Analysis

SWHFX Category Low Category High SWHFX % Rank
Net Assets 801 M 13.9 M 44.3 B 71.57%
Number of Holdings 123 28 362 9.80%
Net Assets in Top 10 353 M 7.98 M 18.8 B 68.63%
Weighting of Top 10 42.29% 24.7% 76.6% 49.02%

Top 10 Holdings

  1. Johnson & Johnson 9.28%

  2. Merck & Co Inc 6.30%

  3. Pfizer Inc 4.96%

  4. UnitedHealth Group Inc 4.03%

  5. Amgen Inc 3.61%

  6. Eli Lilly and Co 3.09%

  7. Roche Holding AG Dividend Right Cert. 2.89%

  8. Abbott Laboratories 2.75%

  9. Thermo Fisher Scientific Inc 2.75%

  10. Gilead Sciences Inc 2.63%


Asset Allocation

Weighting Return Low Return High SWHFX % Rank
Stocks
99.60% 92.71% 99.87% 5.88%
Cash
0.40% 0.00% 7.28% 89.22%
Preferred Stocks
0.00% 0.00% 2.00% 31.37%
Other
0.00% -1.35% 3.29% 52.94%
Convertible Bonds
0.00% 0.00% 0.12% 17.65%
Bonds
0.00% 0.00% 0.09% 25.49%

Stock Sector Breakdown

Weighting Return Low Return High SWHFX % Rank
Healthcare
97.77% 13.80% 99.84% 12.75%
Technology
1.58% 0.00% 61.10% 33.33%
Financial Services
0.25% 0.00% 3.44% 22.55%
Utilities
0.00% 0.00% 0.00% 15.69%
Real Estate
0.00% 0.00% 2.13% 26.47%
Industrials
0.00% 0.00% 10.61% 46.08%
Energy
0.00% 0.00% 0.08% 18.63%
Communication Services
0.00% 0.00% 0.00% 15.69%
Consumer Defense
0.00% 0.00% 0.40% 24.51%
Consumer Cyclical
0.00% 0.00% 7.87% 32.35%
Basic Materials
0.00% 0.00% 0.47% 26.47%

Stock Geographic Breakdown

Weighting Return Low Return High SWHFX % Rank
US
77.93% 62.33% 99.20% 64.71%
Non US
21.67% 0.00% 37.50% 21.57%

SWHFX - Expenses

Operational Fees

SWHFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.80% 0.10% 2.98% 86.27%
Management Fee 0.53% 0.09% 1.25% 3.92%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

SWHFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

SWHFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee 2.00% 0.75% 2.00% 12.50%

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

SWHFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 45.00% 0.00% 699.00% 63.73%

SWHFX - Distributions

Dividend Yield Analysis

SWHFX Category Low Category High SWHFX % Rank
Dividend Yield 0.01% 0.00% 0.01% 4.90%

Dividend Distribution Analysis

SWHFX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Annually Annually

Dividend Payout History


Net Income Ratio Analysis

SWHFX Category Low Category High SWHFX % Rank
Net Income Ratio 0.91% -2.15% 1.48% 5.88%

Capital Gain Distribution Analysis

SWHFX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

SWHFX - Managers

Jonas Svallin

Manager

Start Date

Tenure

Tenure Rank

Aug 03, 2012

6.74

6.7%

Jonas Svallin, CFA, Vice President and Head of Active Equities, has overall responsibility for all aspects of the management of the fund and leads the Active Equities portfolio management and research team. Prior to joining CSIM in 2012, Mr. Svallin spent nearly three years as a partner and a director of quantitative analytics and research at Fiduciary Research & Consulting, where he provided oversight of quantitative analytics and risk management efforts. From 2003 until 2009, Mr. Svallin was a principal and head portfolio manager at Algert Coldiron Investors LLC (now known as Algert Global). Prior to joining Algert, Mr. Svallin worked as a quantitative research associate at RCM Capital Management and a senior consultant at FactSet Research Systems.


Wei Li

Manager

Start Date

Tenure

Tenure Rank

Jun 14, 2013

5.88

5.9%

Wei Li, Ph.D., CFA, Senior Portfolio Manager, is responsible for the day-to-day co-management of the fund. Prior to joining CSIM in 2012, Ms. Li spent more than ten years at BlackRock, Inc. (formerly Barclays Global Investors), where she held a number of positions. From 2001 to 2009, she worked in various roles in the Global Advanced Active group, including portfolio management and quantitative research for both U.S. and international equity markets. After 2009, she worked in the defined contribution research and product development area for almost two years.


Iain Clayton

Manager

Start Date

Tenure

Tenure Rank

Feb 27, 2015

4.17

4.2%

Iain Clayton, CFA, FRM, Senior Portfolio Manager, joined Charles Schwab Investment Management Inc in 2013, Mr. Clayton spent more than five years at SSI Investment Management, where he was a portfolio manager and director of quantitative research. In these roles, Mr. Clayton co-managed multiple investment strategies and developed quantitative models and valuation approaches. From 2004 to 2008, he worked as a portfolio manager and director at RCM Capital Management (now known as Allianz Global Investors) and helped manage various equity portfolios and developed fundamental-based stock selection models. Prior to that, he was a vice president at Eureka Investment Advisors for almost three years and also served as a senior quantitative analyst/assistant portfolio manager. He has also worked as a quantitative research analyst at RCM Capital Management.


Tenure Analysis

Category Low

0.09

Category High

21.64

Category Average

10.34

Category Mode

19.01